JPRN-UMIN000029134已完成未知
Interventional study for substances to reduce impedance at the pad/skin interface during electroconvulsive therapy - Interventional study for substances to reduce impedance at the pad/skin interface during electroconvulsive therapy
Department of Pychiatry, Kitasato University East hospital0 个研究点目标入组 10 人开始时间: 2017年9月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •Otherwise excluded from study participants. (1) if the person or from the Novotel was discontinued participation in research proposal (2) in the PreTac fluid and Gerad Z-101BA until now or further if any allergic symptoms
研究者
相似试验
终止
不适用
Techniques to Reduce the Severity and Frequency of Emergent ReactionsAnalgesiaNCT03832309CHRISTUS Health38
招募中
不适用
Pharmaceutical-pharmacological interventions to improve drug therapy safety of inpatient carelow adherence, problems with drug application/use, patients' concerns regarding their drug therapyDRKS00026088Abteilung Klinische Pharmakologie und Pharmakoepidemiologie, Medizinische Klinik100
已完成
不适用
Evaluation of an intervention to decrease the need for recovery in office employees by increasing daily physical activity and relaxation at work.gezonde medewerkers met hoge herstelbehoefteneed for recoveryNL-OMON36364Delta Lloyd Verzekeringen404
尚未招募
Unknown
Effectiveness of an Intervention for reducing school back pack weights among school students at selected schools in Kanyakumari District, Tamilnadu â??A Mixed Methods StudyCTRI/2023/05/053243MSPRAYTHIESH BRUCE
已完成
4 期
The study of having an inhibitory effect on occuring ocular surface disorders of Blokyleate PF ophthalmic solution 2% in a glaucomatous eye -Controlled trial with Mikelan ophthalmic solution 2%Primary open-angle glaucoma which is in a limited sense, normal tension glaucoma, primary angle-closure glaucoma, exfoliation glaucoma, or high-tension glaucomaJPRN-UMIN000003214ITTEN Pharmaceutical co. ltd.150
